Cheonji Daily



[ad_1]

Valsartan Survey

Made in China, 2.8% of Total Production and Imports

[천지일보=강태우 기자] Korea Food and Drug Administration Domestic Pharmaceuticals Used as Antihypertensives Due to Chinese Valsalt Impurities [19659002] The European Medicines Agency said that N-nitroso dimethylamine (NDMA) has been detected as an impurity in Chinese valsartan and that it is being recovered. .

NDMA is a 2A substance, a potential human carcinogen at the International Institute for Cancer Research of the WHO

In addition, the company has suspended provisional imports and suspended sales of raw materials manufactured by Chinese director Jiang Hua Hua, who are allowed to use valsartan as raw material. In the past three years, the total volume of manufacture and import of valsartan is 484,682 ㎏, and the Chinese manufacturer Valsartan accounts for 2.8% of the total volume of manufacturing and import during the same period .

KFDA is conducting a survey on impurities. Therefore, we will take the necessary steps for collection and disposal. "Although this preliminary step has not yet been identified for the detection of NDMA and the risk of the product, it has been done proactively to protect consumers."

The pharmacist knows that all drugs containing valsartan According to the order of the doctor, the pharmacy can not take prescription.As the warning "prescription prohibition" is registered in the system "service of "safe use", it can not be prescribed by the doctor.

If you have any indications of side effects suspected to be related to the product, you can report it to the Korea Drug Safety Agency (1644-6233, www.drugsafe.or .kr).

  Provisional Suspension and Stay of Medicines (Source: Medicines)
Provisional Suspension and Lists of Controlled Drugs (Source: Medicines)

Copyright © Tianji Daily Reprint and Redistribution Ban

[ad_2]
Source link